Journal article

PF604 THE AUSTRALASIAN LEUKAEMIA AND LYMPHOMA (ALLG) GROUP MM17 TRIAL: RESPONSE ADAPTIVE SALVAGE WITH CARFILZOMIB-THALIDOMIDE-DEXAMETHASONE FOR MULTIPLE MYELOMA PATIENTS FAILING FRONT-LINE BORTEZOMIB

A Spencer, H Quach, N Horvath, I Kerridge, F Yuen, E Lee, E Morris, A Kalff, K Bergin, S Sirdesai, M Gorniak, S Mithraprabhu, T Khong, J Reynolds

HemaSphere | Ovid Technologies (Wolters Kluwer Health) | Published : 2019

University of Melbourne Researchers